logo-dark.png
Aegis Sciences Corporation Announces National Launch of Expanded Novel Psychoactive Substance Testing
27 juil. 2020 12h10 HE | Aegis Sciences Corporation
NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
Premera Blue Cross o
Premera Blue Cross offers zero cost share virtual mental health and substance use disorder treatment during COVID-19 pandemic
21 avr. 2020 15h02 HE | Premera Blue Cross
Mountlake Terrace, Wash., April 21, 2020 (GLOBE NEWSWIRE) -- Premera Blue Cross, a leading health plan in the Pacific Northwest, today announced an expansion of its zero cost share options for...
athenahealth_logo_primary.jpg
athenahealth Hosts Boston Medical Center for Interview Exploring How Data and Insights Will Play a Critical Role in Helping to Reduce Opioid Deaths in the Future
24 févr. 2020 09h00 HE | athenahealth, Inc.
WATERTOWN, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- athenahealth, Inc., a leading provider of network-enabled services for ambulatory and enterprise customers nationwide, has released a new video...
SPRINT PNS MicroLead
SPR Therapeutics Announces 1000th Sprint PNS Procedure
04 déc. 2019 08h30 HE | SPR Therapeutics, Inc.
CLEVELAND, Dec. 04, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced today the successful commercial placement of its 1000th...
ADYNXX_CLEAR.png
Adynxx Reports Third Quarter 2019 Financial Results
14 nov. 2019 06h00 HE | Adynxx, Inc.
SAN FRANCISCO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
Inmar’s LifeInCheck
Inmar’s LifeInCheck Consumer Drug Take-Back Program Works with Hy-Vee to Add Over 200 Additional Drug Disposal Receptacles in Pharmacies in Eight Midwest States
25 oct. 2019 09h59 HE | Inmar, Inc.
Winston-Salem, NC, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Inmar, a data-driven technology-enabled services company, today announced that Hy-Vee, Inc. – an employee-owned supermarket chain – will place...
National Addiction T
National Addiction Treatment Week Highlights the Critical Need for the Medical Community to Treat Addiction
21 oct. 2019 08h39 HE | American Society of Addiction Medicine
Rockville, MD, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Each year, National Addiction Treatment Week (NATW) raises awareness that addiction is a disease, evidence-based treatments are available, and...
ADYNXX_CLEAR.png
Adynxx Receives NIH HEAL Initiative Funding Award for Development of Second Non-Opioid Pain Therapeutic
02 oct. 2019 08h00 HE | Adynxx, Inc.
SAN FRANCISCO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
Progressive Care Website Logo.JPG
NOTICE TO DISREGARD – Progressive Care Inc.
12 sept. 2019 17h17 HE | Progressive Care, Inc.
MIAMI, Sept. 12, 2019 (GLOBE NEWSWIRE) -- We are advised by Progressive Care, Inc. that journalists and other readers should disregard the news release, Progressive Care Inc. Subsidiaries PharmCo...
Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board
30 août 2019 09h00 HE | Endonovo Therapeutics Inc.
LOS ANGELES, Aug. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical®...